2. Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N. Mortality after bariatric surgery: analysis of 13,871 morbidly obese patients from a national registry. Ann Surg. 2007; 246:1002–1007. discussion 1007-1009.
3. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology. 2017; 152:1791–1801.
4. Cho JH, Bilal M, Kim MC, Cohen J; Study Group for Endoscopic Bariatric and Metabolic Therapies of the Korean Society of Gastrointestinal Endoscopy. The clinical and metabolic effects of intragastric balloon on morbid obesity and its related comorbidities. Clin Endosc. 2021; 54:9–16.
5. Seo MH, Kim YH, Han K, et al. Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on national health insurance service health checkup data. J Obes Metab Syndr. 2018; 27:46–52.
6. Ohta M, Maekawa S, Imazu H, et al. Endoscopic intragastric balloon therapy for 15 years in Japan: results of nationwide surveys. Asian J Endosc Surg. 2021; 14:401–407.
7. Abeid M, Kaddah T, Zaitoun NA, Alsamman MA. Efficacy and safety of intragastric balloon placements in 1600 case, an experience from the Middle East. Obes Surg. 2019; 29:2087–2091.
8. Choe Y, Kim JS, Kim BW. Short-term outcomes of intragastric balloon placement for obesity treatment. Korean J Helicobacter Up Gastrointest Res. 2020; 20:318–323.
9. Pak HJ, Choi HN, Lee HC, Yim JE. Effects of intragastric balloon on obesity in obese Korean women for 6 months post removal. Nutr Res Pract. 2021; 15:456–467.
10. Lee KG, Nam SJ, Choi HS, et al. Efficacy and safety of intragastric balloon for obesity in Korea. Clin Endosc. 2023; 56:333–339.